New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export NVAX’s income statement to Excel — free account
Novavax, Inc.
NVAXNovavax, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 64.7% from fiscal 2024.
- Revenue
- −3.05%
- EPS
- n/m
- Free cash flow
- n/m
- Total debt
- +19.3%
Quarter to September 2026, against a year earlier
7.74
0.01
+0.13%
Follow NVAX
Alert me
Where the cash went Fiscal 2025, year to Dec 31, 2025
Free cash flow was −$250.2M: capital expenditures were more than operating cash flow. Cash fell by $289.2M. What is a cash flow statement?
- Free cash flow
- −$250.2M
- Returned to shareholders
- $4.8M
- Debt, net
- $32.5M borrowed
- Change in cash
- −$289.2M over the period
| Operating cash flow | −244.6 |
|---|---|
| Capital expenditures | −5.6 |
| Free cash flow | −250.2 |
| Into investments, net | −91.5 |
| Buybacks, net | −4.8 |
| Debt raised, net | +32.5 |
| Other | +24.8 |
| Change in cash | −289.2 |
Free cash flow
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | −$259M | −$144M | −$185M | −$137M | −$43M | $323M | −$416M | −$714M | −$87M | −$245M |
| Capex | −$18M | −$4.2M | −$1.4M | $16M | −$54M | −$55M | −$89M | −$54M | $180M | −$5.6M |
| Free cash flow | −$277M | −$149M | −$186M | −$120M | −$97M | $268M | −$505M | −$768M | $92M | −$250M |
Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income |
440.30 | (187.50) | (545.06) | (657.94) | (1,743.75) | (418.26) | (132.69) | (184.75) | (183.77) | (279.97) |
Depreciation & Amortization |
27.61 | 48.50 | 41.23 | 29.05 | 12.66 | 4.89 | 5.68 | 9.58 | 11.24 | 9.81 |
Non Cash Items (Other) |
169.40 | 25.07 | 173.75 | 596.00 | 328.06 | 373.90 | 8.03 | 13.93 | 22.01 | 21.50 |
Accounts Receivable Change |
61.04 | 354.09 | (274.44) | 249.17 | (183.39) | (422.69) | — | — | — | 2.07 |
Change in inventories |
(3.24) | 12.91 | (74.46) | (477.80) | (8.87) | — | — | — | — | — |
Change in payables and accrued liability |
(322.57) | (385.63) | (378.80) | 913.40 | 600.33 | 163.16 | (11.48) | (6.74) | 5.19 | (4.81) |
Change in other assets and liabilities |
(622.94) | 67.11 | 350.87 | (1,045.91) | 1,325.56 | 271.55 | (12.53) | (14.40) | (1.87) | (5.96) |
Other operating activities |
5.76 | (21.81) | (7.04) | (21.90) | (7.64) | (15.08) | 6.38 | (2.45) | 2.72 | 0.66 |
Operating Cash Flow |
(244.63) | (87.26) | (713.97) | (415.94) | 322.95 | (42.54) | (136.62) | (184.82) | (144.48) | (258.77) |
Capital expenditures |
(5.56) | 179.59 | (53.77) | (89.06) | (54.50) | (54.47) | 16.48 | (1.37) | (4.19) | (18.20) |
Change in intangibles (net) |
(0.83) | (1.58) | (5.03) | (3.93) | (2.98) | (0.15) | — | — | — | — |
Net Aquisitions |
— | — | — | — | — | (165.52) | 18.33 | — | — | — |
Short Term Investments Change (Net) |
(91.53) | (382.04) | — | — | 157.64 | (157.64) | 22.02 | 29.97 | 40.16 | 46.22 |
Other investing activities |
19.65 | — | — | — | — | — | — | — | — | (39.34) |
Investing cash flow |
(78.27) | (204.04) | (58.81) | (92.98) | 100.15 | (377.78) | 38.49 | 28.60 | 35.97 | 28.02 |
Repayment/Issuance of Debt (Net) |
32.54 | (3.99) | (352.34) | 76.40 | (127.91) | (96.06) | — | — | (0.04) | 314.57 |
Equity Repurchase (Common, Net) |
(4.80) | 264.58 | 360.40 | 248.59 | 589.62 | 881.01 | 98.38 | 102.81 | 64.58 | 3.80 |
Equity Repurchase (Preffered, Net) |
— | — | — | — | — | 199.82 | — | — | — | — |
Other financial activities |
— | — | (3.59) | (5.26) | 320.42 | 358.82 | 14.41 | 12.91 | 26.15 | (38.52) |
Financing cash flow |
27.74 | 260.58 | 4.47 | 324.99 | 461.71 | 984.76 | 98.38 | 102.81 | 64.54 | 279.85 |
Exchange Rate Adjustment |
5.93 | (7.80) | 3.27 | 4.52 | (5.29) | 2.12 | (0.03) | (0.05) | 0.14 | (0.33) |
Change in Cash |
(289.24) | (38.52) | (765.03) | (179.41) | 879.52 | 566.56 | 0.22 | (53.47) | (43.83) | 48.76 |
Beginning Cash |
545.29 | 583.81 | 1,348.85 | 1,528.26 | 648.74 | 82.18 | 81.96 | 135.43 | 179.26 | 130.49 |
Ending Cash |
256.05 | 545.29 | 583.81 | 1,348.85 | 1,528.26 | 648.74 | 82.18 | 81.96 | 135.43 | 179.26 |
Stock Based Compensation |
36.02 | 48.15 | 85.36 | 130.30 | 183.63 | 128.04 | 17.05 | 18.31 | 19.81 | 19.16 |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
(887.71) | 48.48 | (376.84) | (361.15) | 1,733.62 | 12.02 | (24.02) | (21.14) | 3.33 | (10.77) |
Investments Change (Net) |
(91.53) | (382.04) | — | — | 157.64 | (157.64) | 22.02 | 29.97 | 40.16 | 46.22 |
Issuance/Purchase of Shares |
(4.80) | 264.58 | 360.40 | 248.59 | 589.62 | 1,080.83 | 98.38 | 102.81 | 64.58 | 3.80 |
| Other line items | ||||||||||
Revenue per Employee |
1.50 | 0.72 | 0.64 | 0.99 | 0.74 | 0.60 | 0.11 | 0.09 | 0.09 | 0.04 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026